Kezar Life Sciences, Inc. announced that on April 21, 2023, Christopher Kirk, Ph.D. resigned from his role as President and Chief Scientific Officer of athe company. Dr. Kirk remains a member of the Board of Directors of the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.766 USD | -1.28% | -0.48% | -18.87% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.87% | 56.49M | |
+10.05% | 114B | |
+12.29% | 107B | |
-5.80% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-7.11% | 17.51B | |
-39.36% | 17.17B | |
+6.67% | 14.14B | |
+32.96% | 12.2B |
- Stock Market
- Equities
- KZR Stock
- News Kezar Life Sciences, Inc.
- Kezar Life Sciences, Inc. Announces Resignation of Christopher Kirk as President and Chief Scientific Officer